July 25, 2022 | Portfolio News

Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

29

Strategic Financings

30

Exits by IPO or M&A